Unproven therapies in clinical research and practice: The necessity to change the regulatory paradigm

Pediatrics

Volumn 132, Issue 4, 2013, Pages 599-601

  Wootton, Susan H ^a   Evans, Patricia W ^b   Tyson, Jon E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Pediatrix Medical Group   (United States)

Author keywords

Clinical research; Evidence based medicine; Informed consent; Institutional review board; Quality improvement

Indexed keywords

CHLORAMPHENICOL; CORTICOSTEROID; SULFONAMIDE;

ALTERNATIVE MEDICINE; APNEA; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG MEGADOSE; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; LUNG DYSPLASIA; MEDICAL ETHICS; PATIENT CARE; PATIENT EDUCATION; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEPSIS; TREATMENT OUTCOME; UNPROVEN THERAPY; WELLBEING;

CLINICAL RESEARCH; EVIDENCE BASED MEDICINE; INFORMED CONSENT; INSTITUTIONAL REVIEW BOARD; QUALITY IMPROVEMENT;

BIOMEDICAL RESEARCH; HUMANS; NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (U.S.); PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 84885093304     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0778     Document Type: Review

References (7)

1. Rabe H, Diaz-Rossello JL, Duley L, Dowswell T. Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev. 2012;8:CD003248
2. Saugstad OD, Ramji S, Soll RF, Vento M. Resuscitation of newborn infants with 21% or 100% oxygen: an updated systematic review and meta-analysis. Neonatology. 2008;94(3): 176-182
3. Rich WD, Auten KJ, Gantz MG, et al; National Institute of Child Health and Human Development Neonatal Research Network. Antenatal consent in the SUPPORT trial: challenges, costs, and representative enrollment. Pediatrics. 2010; 126(1). Available at: www.pediatrics.org/cgi/content/full/126/1/e215
4. Collins R, Doll R, Peto R. Ethics of clinical trials. In: Williams CJ, ed. Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems. New York, NY: Wiley; 1992:49-65
5. Kass NE, Faden RR, Goodman SN, Pronovost P, Tunis S, Beauchamp TL. The researchtreatment distinction: a problematic approach for determining which activities should have ethical oversight. Hastings Cent Rep. 2013;(spec no):S4-S15
6. Vist GE, Bryant D, Somerville L, Birminghem T, Oxman AD. Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate [review]. Cochrane Database Syst Rev. 2008;(3):MR000009
7. Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis S, Beauchamp TL. An ethics framework for a learning health care system: a departure from traditional research ethics and clinical ethics. Hastings Cent Rep. 2013;(spec no):S16-S27